---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-006428"
form_type: "8-K"
ticker: "BCTX"
cik: "0001610820"
company_name: "BriaCell Therapeutics Corp."
filed_at: "2025-04-28T23:59:59+00:00"
generated_at: "2026-05-23T04:59:17.712638+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# BriaCell closes $13.8M public offering of units with warrants

## Summary
- Gross proceeds of ~$13.8M from 3,066,666 units at $4.50/unit, including 399,999 from over-allotment
- Each unit consists of one common share (or pre-funded warrant) and one warrant exercisable at $5.25 for five years
- Warrants commenced trading on Nasdaq under BCTXZ on April 25, 2025
- Net proceeds to be used for working capital, general corporate purposes, and advancing business objectives
- ThinkEquity acted as sole book-running manager; offering closed on April 28, 2025

## SEC filing metadata
- accession: 0001641172-25-006428
- form_type: 8-K
- ticker: BCTX
- cik: 0001610820
- company_name: BriaCell Therapeutics Corp.
- filed_at: 2025-04-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1610820/000164117225006428/0001641172-25-006428-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1610820/000164117225006428/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-006428
- JSON: https://secwatch.observer/filing/0001641172-25-006428.json
- Plain text: https://secwatch.observer/filing/0001641172-25-006428.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.